Sildenafil and losartan (DrugBank: Sildenafil, Losartan)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
85 | 特発性間質性肺炎 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00981747 (ClinicalTrials.gov) | September 2009 | 19/9/2009 | Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis | A Clinical Treatment Trial Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis | Idiopathic Pulmonary Fibrosis;Pulmonary Fibrosis | Drug: Sildenafil;Drug: Losartan;Drug: Sildenafil and Losartan;Drug: Placebo Oral Tablet | Alicia Gerke | Pulmonary Fibrosis Foundation | Terminated | 18 Years | 99 Years | All | 12 | Phase 2;Phase 3 | United States |